WC
BCYC

Woodstock Corp’s Bicycle Therapeutics BCYC Stock Holding History

Woodstock Corp’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$124K Hold
29,146
– – 0.01% 159
2026
Q1 		$135K Hold
29,146
– – 0.01% 152
2025
Q4 		$206K Buy
29,146
+5,219
+22% +$38.5K 0.02% 154
2025
Q3 		$185K Hold
23,927
– – 0.02% 156
2025
Q2 		$166K Sell
23,927
-1,054
-4% -$8.39K 0.02% 155
2025
Q1 		$212K Hold
24,981
– – 0.02% 151
2024
Q4 		$350K Hold
24,981
– – 0.03% 135
2024
Q3 		$565K Hold
24,981
– – 0.05% 118
2024
Q2 		$506K Hold
24,981
– – 0.05% 118
2024
Q1 		$622K Buy
24,981
+3,502
+16% +$74.4K 0.06% 111
2023
Q4 		$388K Buy
21,479
+926
+5% +$15.3K 0.05% 127
2023
Q3 		$413K Hold
20,553
– – 0.05% 124
2023
Q2 		$525K Buy
20,553
+1,923
+10% +$44.7K 0.06% 119
2023
Q1 		$396K Buy
18,630
+3,790
+26% +$95K 0.05% 132
2022
Q4 		$439K Hold
14,840
– – 0.06% 126
2022
Q3 		$345K Buy
14,840
+4,520
+44% +$108K 0.05% 129
2022
Q2 		$173K Hold
10,320
– – 0.02% 158
2022
Q1 		$453K Sell
10,320
-362
-3% -$16.9K 0.05% 131
2021
Q4 		$650K Hold
10,682
– – 0.07% 124
2021
Q3 		$444K Buy
+10,682
New +$374K 0.05% 142

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Woodstock Corp's BCYC Position: Q2 2026 in Review

Woodstock Corp held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 29,146 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #159.

Woodstock Corp first reported a position in BCYC in Q3 2021 and has held it in 20 quarters since. The position peaked at $650K in Q4 2021. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • Woodstock Corp held 29,146 shares of Bicycle Therapeutics worth $124K as of Q2 2026.
  • Woodstock Corp left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up 0.01% of Woodstock Corp's portfolio in Q2 2026, its #159 holding.
  • Woodstock Corp first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • Woodstock Corp's Bicycle Therapeutics position peaked at $650K in Q4 2021.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on Woodstock Corp's 13F filing for Q2 2026, filed 13 Jul 2026.